AVBPArriVent BioPharma, Inc.

$31.16

Is the price fair?

What AVBP's price assumes

Price / book
3.21

Price / book · as of 2026-Q1

Details
Price / book2026-Q1
3.21
Market capitalisation
$1.48B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.